Medically actionable variants were also identified in two other cancer-related genes, including BRCA2 and MSH6, which are associated with hereditary breast and/or ovarian cancer and Lynch syndrome, respectively (Table 1) [16,17,18,19,20]. This evidence concerns the gene BRCA2 and Lynch syndrome.